Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients
Clinical trial NCT06683131 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06683131
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-20
- Primary completion
- 2027-11-30
- Enrollment
- 1160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.